XORTX Therapeutics (XRTX) Invested Capital (2020 - 2021)
XORTX Therapeutics' (XRTX) quarterly Invested Capital came in at $556127.8 in Q4 2021, down 29.9% YoY from $793297.9 in Q4 2020, and down 29.9% on a QoQ basis from $793297.9 in Q4 2020.
XORTX Therapeutics (XRTX) Invested Capital (2020 - 2021) Analysis & Trends
XORTX Therapeutics (XRTX) has 2 years of Invested Capital data on file, last reported at $556127.8 in Q4 2021.
- Quarterly Invested Capital fell 29.9% year-over-year to $556127.8 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $556127.8 (down 29.9% YoY) and the FY2021 annual result came in at $559366.0, down 29.49% from the prior year.
- Invested Capital slipped to $556127.8 in Q4 2021, from $793297.9 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $793297.9 in Q4 2020 to a low of $556127.8 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 556,127.80 |
| Dec 31, 2020 | 793,297.91 |